March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it could be a heart attack. She was 36, a new mom, and otherwise healthy.

At the hospital, blood tests showed signs of a heart attack, but her arteries appeared normal.

March 30, 2026 — Partho Sengupta, MD, DM, FACC, FASE, was honored as a 2026 Distinguished Scientist (Translational Domain) at the national American College of Cardiology (ACC) Conference in New Orleans.

Dr. Sengupta is Chief of Cardiology at Robert Wood Johnson University Hospital (RWJUH) and Rutgers Robert Wood Johnson Medical School (RWJMS). RWJUH is an RWJBarnabas Health facility.

March 24, 2026 — Starlight Cardiovascular recently announced that the first baby in the world was treated with its Lifeline Ductus Arteriosus Stent System at Cincinnati Children's Hospital in January. The device is currently being studied under a U.S. Food and Drug Administration Investigational Device Exemption clinical trial.

March 29, 2026 — Medical AI, a company specializing in artificial intelligence-enabled electrocardiogram (ECG) solutions for cardiovascular disease detection and monitoring, received the inaugural Global Digital Health Award at the American College of Cardiology’s (ACC) Annual Scientific Session.

The award was presented by Dr. Ami Bhatt, Chief Innovation Officer of the ACC, during the conference’s Future Hub Theater session, which highlights breakthrough technologies shaping the future of cardiovascular medicine.

March 24, 2026 — Anumana has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled software-as-a-medical-device (SaMD) that detects early signs of PH, a serious and progressive condition affecting the lungs and right side of the heart. The algorithm, which previously received FDA Breakthrough Device Designation, is the first PH algorithm cleared for use with standard 12-lead electrocardiograms (ECGs), making it broadly accessible across care settings.

March 28, 2026 — Medtronic has announced the EMBRACE trial, led by Dr. Roxana Mehran, Professor of Medicine and Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Wiener Cardiovascular Institute at the Icahn School of Medicine at Mount Sinai, and Dr. Felix Mahfoud, Professor of Cardiology at the University of Basel and Chief of Cardiology at the University Hospital Basel.

March 28, 2026 — Randomized controlled trial (RCT) data presented at the American College of Cardiology (ACC) 2026 and simultaneously published in the Journal of the American College of Cardiology demonstrates for the first time that supporting the left ventricle (LV) with an Impella CP for more than 40 minutes prior to reperfusion does not reduce nor increase heart muscle damage, known as a myocardial infarction. Greater infarct size correlates to a higher risk of dying or developing heart failure, a condition that impacts more than 55 million worldwide1.

March 26, 2026 —The heart’s ability to use oxygen efficiently is a critical indicator of its health, but tests to measure this function have drawbacks that can limit their use. A new Cedars-Sinai Health Sciences University study found that a new MRI system developed at Cedars-Sinai might overcome this challenge.

March 25, 2026 — Royal Philips has received U.S. Food and Drug Administration (FDA) 510(k) clearance for EchoNavigator R5.0 with DeviceGuide, an AI-powered software solution that assists physicians during one of interventional cardiology’s most technically demanding procedures – repairing leaking mitral valves through a minimally invasive approach. 

March 25, 2026 — At the 75th Annual Scientific Session & Expo of the American College of Cardiology (ACC.26) in New Orleans, Cleerly will launch Cleerly PREVIEW, a new workflow-support enhancement designed to assist clinicians with case prioritization and streamline administrative processes, such as prior authorization, for coronary artery disease (CAD) imaging.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now